ADPT SEC Filing News — Adaptive Biotechnologies Corporation

ADPT insider RUBINSTEIN JULIE (President and COO) sold 35,643 shares (~$897.4K)

RUBINSTEIN JULIE, listed as President and COO at Adaptive Biotechnologies Corp, reported an open-market sale of 35,643 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider RUBINSTEIN JULIE (President and COO) sold 35,643 shares (~$919.9K)

RUBINSTEIN JULIE, listed as President and COO at Adaptive Biotechnologies Corp, reported an open-market sale of 35,643 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider RUBINSTEIN JULIE (President and COO) sold 35,643 shares (~$948.2K)

RUBINSTEIN JULIE, listed as President and COO at Adaptive Biotechnologies Corp, reported an open-market sale of 35,643 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider BOBULSKY SUSAN (Chief Commercial Officer, MRD) sold 6,444 shares (~$193.3K)

BOBULSKY SUSAN, listed as Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp, reported an open-market sale of 6,444 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider RUBINSTEIN JULIE (President and COO) sold 35,643 shares (~$1.01M)

RUBINSTEIN JULIE, listed as President and COO at Adaptive Biotechnologies Corp, reported an open-market sale of 35,643 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider LO FRANCIS (Chief People Officer) sold 26,792 shares (~$757.7K)

LO FRANCIS, listed as Chief People Officer at Adaptive Biotechnologies Corp, reported an open-market sale of 26,792 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider LO FRANCIS (Chief People Officer) sold 115,406 shares (~$3.24M)

LO FRANCIS, listed as Chief People Officer at Adaptive Biotechnologies Corp, reported an open-market sale of 115,406 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider BOBULSKY SUSAN (Chief Commercial Officer, MRD) sold 1,195 shares (~$32.3K)

BOBULSKY SUSAN, listed as Chief Commercial Officer, MRD at Adaptive Biotechnologies Corp, reported an open-market sale of 1,195 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider Form 4 filed for equity award, exercise, or tax withholding

OWEN KATEY EINTERZ (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

ADPT insider OWEN KATEY EINTERZ (Director) sold 9,615 shares (~$250.0K)

OWEN KATEY EINTERZ, listed as Director at Adaptive Biotechnologies Corp, reported an open-market sale of 9,615 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider HERSHBERG ROBERT (Director) sold 30,664 shares (~$748.2K)

HERSHBERG ROBERT, listed as Director at Adaptive Biotechnologies Corp, reported an open-market sale of 30,664 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider ROBINS CHAD M (Director, CEO and Chairman) sold 600,000 shares (~$14.88M)

ROBINS CHAD M, listed as Director, CEO and Chairman at Adaptive Biotechnologies Corp, reported an open-market sale of 600,000 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT insider NEUPERT PETER M (Director) sold 124,690 shares (~$3.14M)

NEUPERT PETER M, listed as Director at Adaptive Biotechnologies Corp, reported an open-market sale of 124,690 ADPT shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

ADPT Form 144 filed for proposed insider sale by SUSAN BOBULSKY (6,444 shares) ~$192.3K

SUSAN BOBULSKY filed a Form 144 with the SEC indicating intent to sell ADPT (Adaptive Biotechnologies Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

ADPT Form 144 filed for proposed insider sale by JULIE RUBINSTEIN (379,777 shares) ~$10.98M

JULIE RUBINSTEIN filed a Form 144 with the SEC indicating intent to sell ADPT (Adaptive Biotechnologies Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

ADPT Form 144 filed for proposed insider sale by FRANCIS LO (142,198 shares) ~$3.79M

FRANCIS LO filed a Form 144 with the SEC indicating intent to sell ADPT (Adaptive Biotechnologies Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

ADPT Form 144 filed for proposed insider sale by SUSAN BOBULSKY (1,195 shares) ~$29.6K

SUSAN BOBULSKY filed a Form 144 with the SEC indicating intent to sell ADPT (Adaptive Biotechnologies Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

ADPT Form 144 filed for proposed insider sale by KATHERINE E OWEN (9,615 shares) ~$250.0K

KATHERINE E OWEN filed a Form 144 with the SEC indicating intent to sell ADPT (Adaptive Biotechnologies Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

ADPT Form 144 filed for proposed insider sale by Harlan Robins (402,160 shares) ~$10.23M

Harlan Robins filed a Form 144 with the SEC indicating intent to sell ADPT (Adaptive Biotechnologies Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

ADPT Form 144 filed for proposed insider sale by Harlan Robins (215,632 shares) ~$5.50M

Harlan Robins filed a Form 144 with the SEC indicating intent to sell ADPT (Adaptive Biotechnologies Corp) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.